Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The School for Primary Care Research would like to congratulate Professor Alastair Hay on his appointment to chair a NICE guideline development group for antimicrobial stewardship medicines practice.

A nice chair for antimicrobial guideline development

Currently in receipt of funds from the School, Alastair is principal investigator on a randomised trial to consider the clinical and cost effectiveness of oral steroids in the treatment of acute lower respiratory tract infection. This is a collaborative study between the universities of Bristol, Southampton, Nottingham, Sheffield and Oxford.

In 2008, Alastair was funded by the School to conduct a feasibility study to investigate the relationship between primary care prescribed antibiotics and antimicrobial resistance, and its associated costs, among symptomatic adults assessed in secondary care with infection.

I am delighted to be offered this opportunity by NICE and to influence a topic of international importance and central to the preservation of future antibiotic effectiveness." - Alastair Hay


See further details on the how to apply to become a member of the development group on the NICE website. Closing date: 2 April 2015.